Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737535) titled 'Investigating Clinical Heterogeneity in Immune Checkpoint Inhibitor-induced Inflammatory Arthritis' on July 27.

Study Type: Observational [Patient Registry]

Primary Sponsor: Johns Hopkins University

Condition: Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis

Recruitment Status: Not recruiting

Date of First Enrollment: July 1, 2026

Target Sample Size: 1000

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07737535

Disclaimer: Curated by HT Syndication....